199 related articles for article (PubMed ID: 10664114)
21. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Yuasa Y; Sueda T
World J Surg; 2010 Aug; 34(8):1900-7. PubMed ID: 20376442
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience.
Takai S; Satoi S; Toyokawa H; Yanagimoto H; Sugimoto N; Tsuji K; Araki H; Matsui Y; Imamura A; Kwon AH; Kamiyama Y
Pancreas; 2003 Apr; 26(3):243-9. PubMed ID: 12657950
[TBL] [Abstract][Full Text] [Related]
23. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
24. Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?
Konstantinidis IT; Deshpande V; Zheng H; Wargo JA; Fernandez-del Castillo C; Thayer SP; Androutsopoulos V; Lauwers GY; Warshaw AL; Ferrone CR
J Gastrointest Surg; 2010 Feb; 14(2):261-7. PubMed ID: 19937477
[TBL] [Abstract][Full Text] [Related]
25. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T
Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836
[TBL] [Abstract][Full Text] [Related]
27. Ductal adenocarcinoma of the pancreas. Histopathological features and prognosis.
Tannapfel A; Wittekind C; Hünefeld G
Int J Pancreatol; 1992 Oct; 12(2):145-52. PubMed ID: 1460329
[TBL] [Abstract][Full Text] [Related]
28. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
[TBL] [Abstract][Full Text] [Related]
29. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
30. Survival after resection for ductal adenocarcinoma of the pancreas.
Sperti C; Pasquali C; Piccoli A; Pedrazzoli S
Br J Surg; 1996 May; 83(5):625-31. PubMed ID: 8689203
[TBL] [Abstract][Full Text] [Related]
31. Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas.
Benassai G; Mastrorilli M; Quarto G; Cappiello A; Giani U; Mosella G
Chir Ital; 2000; 52(3):263-70. PubMed ID: 10932371
[TBL] [Abstract][Full Text] [Related]
32. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.
Pedrazzoli S; DiCarlo V; Dionigi R; Mosca F; Pederzoli P; Pasquali C; Klöppel G; Dhaene K; Michelassi F
Ann Surg; 1998 Oct; 228(4):508-17. PubMed ID: 9790340
[TBL] [Abstract][Full Text] [Related]
33. Histopathological determinants of survival in resected cases of pancreas cancer.
Brower ST; Newman RM; Pertsemlidis D; Kreel I; Aufses AH
HPB Surg; 1993 Aug; 7(1):1-12; discussion 13-4. PubMed ID: 8260431
[TBL] [Abstract][Full Text] [Related]
34. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
35. Lymphatic involvement in early gastric cancer: prevalence and prognosis in France.
Borie F; Millat B; Fingerhut A; Hay JM; Fagniez PL; De Saxce B
Arch Surg; 2000 Oct; 135(10):1218-23. PubMed ID: 11030885
[TBL] [Abstract][Full Text] [Related]
36. Long-term survival after curative resection for pancreatic ductal adenocarcinoma--Surgical treatment.
Benassai G; Quarto G; Perrotta S; Furino E; Benassai GL; Amato B; Bianco T; De Palma G; Forestieri P
Int J Surg; 2015 Sep; 21 Suppl 1():S1-3. PubMed ID: 26118618
[TBL] [Abstract][Full Text] [Related]
37. Extended lymphadenectomy in cephalic pancreatoduodenectomy. Personal observations.
Meriggi F; Gramigna P; Forni E
Hepatogastroenterology; 2007 Mar; 54(74):549-55. PubMed ID: 17523320
[TBL] [Abstract][Full Text] [Related]
38. [Diagnosis of tumor extension of ductal adenocarcinoma of the pancreas based on histological findings].
Hatori T; Takasaki K; Imaizumi T; Nakasako T; Harada N; Fukuda A
Nihon Geka Gakkai Zasshi; 1997 Jul; 98(7):604-9. PubMed ID: 9276866
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive histological evaluation with clinical analysis of venous invasion in pancreatic ductal adenocarcinoma: From histology to clinical implications.
Lee SJ; Sung YN; Kim SJ; Shin S; Cho H; Hruban RH; Hong SM
Pancreatology; 2020 Oct; 20(7):1486-1494. PubMed ID: 32948429
[TBL] [Abstract][Full Text] [Related]
40. Prognostic importance of isolated peritumoral lymphangiosis carcinomatosa in lymph-node-negative colorectal carcinoma.
Meyer W; Awad-Allah A; Steinhäuser BB; Jurowich C; Kaiser A; Gebhardt C
Langenbecks Arch Surg; 2001 Mar; 386(2):124-31. PubMed ID: 11374045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
